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Abstract

Introduction

This review paper characterizes glass-ceramics containing mica as main crystal phase. The phase formation
reactions in dependence of the chemical composition and
the microstructure are shown. Microstructure of mica
glass-ceramics has been studied by ele..ctron replica and
scanning electron microscopic (SEM) techniques.
Mica glass-ceramics have previously been developed
in Si02-B 20rA120rMgO-F--base glasses. The material
is machinable because of the precipitation of micas of
fluorophlogopite-type. Also, a machinable glass-ceramic
for dental applications was developed based on
KMg 2_5 (Si 40 10)Frmicas. We developed mica glass-ceramics in the Si02-Al 20rMgO-NaiO-K20-F glass system. Phase formation within these glasses was observed
by SEM. A double controlled nucleation and crystallization of mica and apatite crystals was possible in glasses
of the SiOrMgO-NaiO-K20-F-CaO-P20s-(Al 20 3) system. The main crystal phases of phlogopite-type were
characterized by SEM and energy dispersive x-ray spectroscopy (EDS) and apatite crystals Ca5(P0 4)J(OH,F)
were analyzed by X-ray diffraction measurements. The
glass-ceramics are useful biomaterials for bone substitution. EDS analysis shows the ion exchange between
glass-ceramics and body fluids. The interface reaction
is characterized by formation of a small phosphate layer,
and particularly by alkali ion exchange.

The first machinable glass-ceramic, which contains
mica as main crystal phase is MACOR® which was developed by Beall et al. (1971). The composition of the
base glass is 47.2 Si02, 8.5 B20 3 , 16.7 Al 20 3 , 14.5
MgO, 9.5 K2 and 6.3 F.
A special method of controlled nucleation via phase
separation and crystallization of silicate glasses has been
used by Beall et al. (1971) to precipitate fluorophlogopite, namely KMg3(AlSi3 0 10)F 2 as main crystal
phase. The result was a glass ceramic which could be
machined with standard metal working tools. Because
of the combination of favorable properties, such as
machinability and electrical isolation, very interesting
technological applications can be considered. In order
to ensure good machinability the precipitated mica crystals in the glass matrix need an optimal size and contact
with each other. The material is machinable because of
the preferred cleavage of the micas. Beall (1979) called
the microstructure of the glass ceramic a "house of cards
structure", which describes the orientation of the micas
in the glassy phase.
Based on this development of Beall et al. (1971)
further mica glass-ceramics (e.g. , Beall, 1991) have
been developed also for medical applications. The
authors of the present paper review these developments
(see chapters "glass-ceramic of DICOR®-type",
"precipitation of micas rich in ea2+ -ions").
Further mica type glass-ceramics for technical purposes have been developed by Vogel et al. (1973) in the
magnesium-aluminosilicate base glass system. Based on
these investigations, the authors of this paper developed
a phlogopite-type glass ceramic for medical application.
This glass ceramic is biocompatible but not bioactive
(see chapter "glass-ceramic of BIOVERIT® II-type").
The development of bioactive biomaterials has
strongly been influenced by Hench et al. (1972) who
developed the biomaterial BIOGLASS® from the SiOiNaiO-CaO-P20rF system. The new biomaterials show
bioactive properties and the materials are bonded to
living bone. BIOGLASS® forms apatite on the surface
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interface reactions, microstructure, phase formation,
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Figure 1. Microstructure of DICOR* glass ceramic observed during replica investigation of fracture surface in a
transmission electron microscope (fEM). Specimen was etched for 5 seconds in 1 % HF.
Figure 2. SEM of cross-section through globular aggregates of curved phlogopite showing initial stage of crystallization. Polished sample and etched 2.5 seconds in 2 % HF.
Figure 3. Advanced stage of the precipitation of curved phlogopite crystals. SEM. Polished sample and etched 2.5
seconds in 2 % HF.
Figure 4. Curved phlogopite crystals in glass ceramics (BIOVERIT* II-type) having high translucency.
Polished sample and etched 2.5 seconds in 2 % HF.

SEM.

ing strength. Hence, the material is used in dental
medicine as crowns.

in contact and reaction with the body fluid and the living
bone. On the basis of the knowledge of this apatite formation in BIOGLASS*, further bioactive glass-ceramics,
containing apatite crystals, have been developed
(Blencke et al., 1977; Strunz et al., 1978).
Kokubo et al. (1982) showed a preferred bonding of
bone and apatite-wollastonite glass ceramic, and an additional apatite formation in reaction with simulated body
fluid could be shown on the surface of the biomaterial
(Kokubo et al., 1990).
The authors of this present paper developed a
machinable bioactive glass-ceramic consisting of two
crystal phases, namely mica and apatite, and a glassy
phase. The microstructure and the properties, especially
the interphase reactions between mica and bone are presented (see chapter "BIOVERIT* I-type glass-ceramics"). Other glass-ceramics containing micas and phosphates are reviewed (see "glass-ceramics containing
micas and CaO-, P20s-additives").

Glass-Ceramics of BIOVERIT* II-Type
(Mica Glass-Ceramic)
The crystallization behavior of magnesium-aluminosilicate base glasses was investigated by Vogel et al.
(1973). N820, K20 and F were added to Si~-Al 2 0r
MgO-glasses and the mica precipitation has been studied. Based on these results, Roland et al. (1981)
analyzed the phase formation processes in glasses of the
composition: 43-50 Si~, 26-30 Al20 3, 11-15 MgO, 710 R20, 3.3-4.8 F, 0.01-0.6 Cl, 0.1-3 CaO, 0.1-5
P 20 5 , wherein R20 is the sum of 3-5.5 wt. % N820 and
4-6 wt. % K 20. A new type of phlogopite in a curved
shape was precipitated in a glass ceramic. The formation of this new phlogopite was investigated in a glass
with the chemical composition (wt. %): 44.5 Si~, 29.9
Al203, 11.8 MgO, 4.2 F, 4.4 Na2, 4.9 K10, 0.1 Cao,
0.1 P 20 5 , 0.1 Cl by TEM and SEM (HOland et al.,
1991a). The chemical composition of this new curved
mica, (N a 0 . 18 K0 . 82)(Mg 2 _24AI 0 . 61 )(Si2 .78 Al 1.22 )
010.1of1.90could be analyzed by energy dispersive spectroscopy (EDS) (Roland et al., 1991a).
In comparison to glasses which form flat mica crystals, the control of the reduced phase separation process
allowed the formation of the new curved mica crystals
(HOland et al., 1981). Because of a low concentration
of nucleating centers, curved micas and cordierite
crystals (as secondary crystal phase) grow in the range
700-1050 °C. The phase formation and the structure of
curved mica crystals, that are typical for glass-ceramics
ofBIOVERIT* II-type, have been studied in comparison
to flat crystals (Vogel and ROiand, 1982; Roland et al.,
1983b; Elsen et al. 1989). Crystal structure investigation by X-ray diffractometry of phlogopite micas showed
that the curved mica has a still higher content of aluminum ions in the octahedral coordination.
Small glassy phase separated droplets are the nucleating centers of the curved phlogopite. Curved phlogopites grow as isolated ball shaped aggregates (Figure
2). The crystallization up to 980 °C can be controlled
so that the curved crystals come into contact with each

Glass-Ceramic of DICOR*-Type
(Mica Glass-Ceramic)
Grossman (1972, 1983) crystallized glasses consisting essentially of 45-70 % Si~, 8-20 % MgO, 8-15 %
MgF2, 5-35 % R 20 and RO; where R 20 consists of
K20, R~O and C520 and RO consists of SrO or BaO
and other alkaline earth oxides. Additions, such as
Zr02, A1 20 3 and colourants were used.
These
investigations have been the basis for the development of
a glass of the composition (in weight percent): 60.9
Si02, 0.6 A120 3, 17.1 MgO, 13.8 K20, 4.9 F, 4.7
Zr02, 0.05 Ce02 (Adair, 1984). Ce02 can give the
glass-ceramic fluorescence. This glass was heat treated
and the microstructure was investigated by scanning
electron microscopy (SEM) (Grossman, 1989; Adair,
1984).
Grossman (1989) showed that the base glass is
phase separated and mica crystals of KMg2_5Si40u12type grow during heat treating the glass from 625 to
1075 °C. A typical microstructure is shown in Figure
1 (the preparation technique is indicated in the caption of
the Figure). The glass ceramic shows excellent properties, such as machinability, translucency and good bend106
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The experiences of the surgeon (Beleites et al.,
1988) showed that middle ear implants have to have a
very good machinability, that means a high content of
curved micas (Beleites et al., 1988) and dental products
should show a special translucency.

Precipitation of Micas Rich in Ca2 + -Ions
Silicate glasses rich in CaO were developed by Ehrt
and Heidenreich (1978), and Kasuga and Kasuga (1991) .
A characteristic composition which has been investigated
by Ehrt and Heidenreich was 50 % SiOi, 18 % A120 3 ,
7 % MgO, 10 % CaO, 3.5 % N310, 4.5 K 20, 7 Ma. %
F. Kasuga and Kasuga (1991) could get glass-ceramics
of the composition 43 .5 Si02, 12. 7 Al 20 3 , 25.5 MgO,
6.5 CaO, 1.7 K20 and 10. 1 F. The main crystal phase
is a mica rich in Ca2+ -ions and secondary phases, such
as diopside, anorthite, richterite and others were precipitated in the glass-ceramic (Kasuga and Kasuga,
1991).
Developments of Ehrt and Heidenreich (1978) and
Kasuga and Kasuga ( 1991) to increase the Cao-content
in mica type glass-ceramics had given the possibility to
develop machinable glass ceramics with high mechanical
strength (bending strength 210-300 MPa). The microstructure of the glass ceramic formed by Kasuga and
Kasuga contains mica and diopside crystals and a glass
matrix phase. An application for dental crowns was
proposed by Kasuga and Kasuga (1991) .

Figure 9. Interface between bone (guinea pig) and
mica-apatite glass ceramic (BIOVERIT® I) one year
after implantation.
Figure 5. Mica-cordierite glass-ceramic (BIOVERIT®
II-type). The precipitation of cordierite takes place
between the curved mica plates. SEM. Polished sample
and etched 2. 5 seconds in 2 % HF .

BIOVERIT® I-Type Glass-Ceramics
(Mica-Apatite Glass-Ceramics)
A combination of different properties within a glass
ceramic material, especially the combination of machinability and bioactivity was possible in multi-component
glasses of the SiOi-(A1 20 3 )-MgO-NaiO-K20-P--Ca0P205 system. Typical compositions are 35.9 Si02, 18.1
A1 20 3 , 6.5 MgO, 5.1 Na20, 4.0 K20, 16.7 CaO, 11.2
P20 5 and 2.5 wt. % F_ or 38.7 Si02, 1.4 Al 20 3 , 27.7
MgO, 6.8 K 20, 10.4 CaO, 8.2 P20 5 and 1.9 wt. %
Ti02 (Roland et al., 1983a, Roland et al., 199la).
Mica-apatite glass-ceramics show a characteristic
microstructure and phase formation reactions (Vogel and
Roland, 1987). The base glass shows three glassy
phases, a Si02-ricb glass matrix, a CaO-P 20rF--rich
big droplet phase, and a Na20-K20-Al 20rMgO-P--rich
b~g droplet phase (Figure 6). Heat treating the glass at
temperatures between 610 and 1050 °C allowed a double
controlled in situ crystallization of mica and apatite.
Apatite grows inside the CaO-P 20rF-rich big droplet
phase (Figure 7) and phlogopite formation is a result of
a solid state reaction of the glass matrix phase and the
small droplet phase (Figure 8). The apatite crystals of

Figure 6. Base glass of mica-apatite glass-ceramic.
The glass consists of three glassy phases. TEM/replica.
Fractured surface etched 5 seconds in H Cl.
Figure 7. Precipitation of Ca5(P04 )J(OH,F) apatite
within the CaO-P20 5-F rich droplet phase. TEM/replica. Fractured surface etched 5 seconds in HCI.
Figure 8. Mica.apatite glass-ceramic after one week in
Ringer's solution. TEM/replica.
other (Figure 3). The content of crystals within the
glass-ceramic can be varied, e.g., lowered in comparison to Figure 3 and the translucency becomes higher
(Figure 4).
Varying the chemical composition, to add more
MgO and Al 20 3 to the melt, it is possible to increase the
content of the second crystal phase, cordierite (Figure
5). Therefore, the properties of the glass-ceramic, such
as translucency, mechanical properties and thermal expansion coefficient can be controlled depending on the
particular application in medicine (Roland et al. , 199 la).
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Ca5(P04)J(OH,F)-type could be determined by X-ray
diffraction measurements and the flat phlogopitecrystals,
(Nao.21Ko.s1)(Mgo.52Alo.44)(Si2.8oA11 .20)010.18F 1.s2
could be analyz.ed by EDS (Holand et al., 1983 a,
1985).
The authors of the present paper assume that similar
reactions take place in glasses containing low concentrations of Al 20 3 (or Al 20rfree glasses). The difference
between the phase formation in glasses shown in Figures
6-8 is that the phases formed are very small and the
mica consists of KMg2 .s(S4010)F2-type.
Electron microprobe investigations carried out by
Holand et al. (1991b) show a very good contact of micaapatite glass-ceramic and bone. One year after operation, the reaction interface between bone (tibia of guinea
pig) and mica-apatite glass-ceramic is less than 15 µm
(Figures 9 and 10). Apatite is present within the biomaterial but an additional small calcium phosphate layer
will be formed on the surface of the glass-ceramic. Secondary ion mass spectroscopy (SIMS) investigations
show the tendency that phosphate groups become enriched at the surface of BIOVERIT* I glass-ceramics
under simulated conditions (Holand et al., 1991b).
Figure 11 shows that the peak positions 31, 47 and 63
are responsible for the enrichment of phosphate groups.
Additionally an NaCl-rich layer from the simulated body
fluid seems to be deposited onto the sample (position 35,
37).
The process of bioactivity seems to be of a complex
nature. It includes solid state reactions (apatite-apatite
reaction), ion diffusion processes (e.g. Na+-, ea2+ -diffusion), Ca-phosphate formation and a possible positive
influence of silicates (Hench, 1991) on the bone regeneration reaction. This corresponds with results of bioactive behavior of glasses and glass-ceramics reported by
Hench (1991), Kokubo et al. (1990), and Wilson (1991).

Conclusiom
The results of the authors of papers cited in the bibliography and the authors of this paper showed that mica
glass-ceramics are biocompatible materials which can be
used for bone substitution in medicine.
DICOR~-type glass ceramic is used for dental
restoration. Mica glass-ceramics of BIOVERIT* IT-type
and mica-apatite glass ceramics of BIOVERIT* I-type
have been successfully applied in head and neck surgery
and orthopaedic surgery in more than 600 patients
(Schubert et al., 1988; Holand et al., 1990).
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Reviewer III: The paper reviews some material aspects of glass-ceramics that are considered by the inventors to be biocompatible. The biological behavior of this type of material is neither investigated,
nor documented, nor published carefully enough!
Authors: The biomaterials which have been developed at Otto-Schott-Institute of Jena University are
glass-ceramic of BIOVERIT® type. The biocompatibility of BIOVERIT® I-type has been investigated by
J. Gummel, T. Schubert, K.J. Schulze and W.
Purath and are documented in qualification thesis of
orthopaedic clinic, Dresden, Germany and partly in
the text reference Schubert et al., 1988. The biocompatibility of BIOVERIT® II-type is shown by E.
Beleites, University Jena, clinic for otorhinolaryngology and the results are documented in his
qualification theses and partly in text reference
Beleites et al. (1988), and in Vogel and Roland
(1987).
The well established cell culture test method was
utilized for the determination of toxicity for both
ceramic types. Neither the "bioactive" ceramics nor
the "bioinert" reference materials demonstrated a
significant influence on the cellular activity
(proliferation).
Additional testing protocols are documented in
the references listed previously. We have also performed further biocompatibility studies with laboratory animals: Sixteen weeks after subcutaneous implantation of Bioverit I, with its higher solubility , a
stabilization of the cellular reaction was observed.
The investigators concluded that this result can be
interpreted as a sign of controlled surface solubility
factors and excellent biocompatibility.
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